Ignacio I. Wistuba

Top papers

• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  William D. Travis, Élisabeth Brambilla, Masayuki Noguchi, et al.·2011·Journal of Thoracic Oncology
  ↗ 4,822OA
• The 2015 World Health Organization Classification of Lung Tumors

  William D. Travis, Élisabeth Brambilla, Andrew G. Nicholson, et al.·2015·Journal of Thoracic Oncology
  ↗ 4,491
• Somatic mutations affect key pathways in lung adenocarcinoma

  Li Ding, Gad Getz, David A. Wheeler, et al.·2008·Nature
  ↗ 2,734OA
• Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

  Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, et al.·2014·JAMA
  ↗ 1,733
• <i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

  Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, et al.·2018·Cancer Discovery
  ↗ 1,583OA
• PD-L1 as a biomarker of response to immune-checkpoint inhibitors

  Deborah B. Doroshow, Sheena Bhalla, Mary Beth Beasley, et al.·2021·Nature Reviews Clinical Oncology
  ↗ 1,525
• Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

  Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, et al.·2017·The Lancet Oncology
  ↗ 1,387OA
• An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

  Lauren A. Byers, Lixia Diao, Jing Wang, et al.·2012·Clinical Cancer Research
  ↗ 1,120OA
• Characterizing the cancer genome in lung adenocarcinoma

  Barbara A. Weir, Michele Sue‐Ann Woo, Gad Getz, et al.·2007·Nature
  ↗ 1,118OA
• Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

  Pei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.·2016·Cancer Discovery
  ↗ 1,006OA
• Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

  Jianjun Zhang, Junya Fujimoto, Jianhua Zhang, et al.·2014·Science
  ↗ 1,003
• Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

  Limo Chen, Don L. Gibbons, Sangeeta Goswami, et al.·2014·Nature Communications
  ↗ 984OA